Recruiting NCT04697823
Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: use of hyaluronan-enriched transfer medium.
- Who it may be relevant to
- Registry conditions: Hyaluronan-EnRiched Medium, Randomized Controlled Trial. Basic parameters: 18 years — 40 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Belgium
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of Hyaluronan-enriched Medium on the Cumulative Ongoing Pregnancy Rate: a Prospective Randomized Trial
Overview
Assessing whether the use of hyaluronan-enriched transfer medium can increase the cumulative ongoing pregnancy rate
Interventions
- Other use of hyaluronan-enriched transfer medium
In the study group, an embryo transfer will be performed in hyaluronan-enriched transfer medium
Primary outcome measures
- number of transfers needed to reach ongoing pregnancy [Time frame: ongoing defined as a pregancy with a viable fetus with FHB at 12 weeks of pregnancy]
Secondary outcome measures (1)
- number of transfers needed to reach clinical pregnancy, life birth, miscarriage, multiple pregnancy [Time frame: until Live birth: 9 months after ET]
Eligibility criteria
Inclusion criteria
- Patients with own oocytes/embryos;
- Patients with female age at 1st OR in the study <40 year;
- Patients planned for a 2nd oocyte retrieval, with no clinical ongoing pregnancy after the previous oocyte retrieval
- Patients planned for a 3rd oocyte retrieval with no clinical ongoing pregnancy after previous oocyte retrievals
- Patients with female age at 1st OR in the study <40 year;
- Patients with BMI ≤32;
- Patients with written informed consent;
Exclusion criteria
\-
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Double blind
- Primary purpose
- Treatment
Study locations
Belgium · 1 center
- Leuven University Fertility Center — Leuven
Identifiers
NCT: NCT04697823 · S64387